Given the strict blood pressure targets for patients with diabetes mellitus and the high/very high cardiovascular risk associated with DKD, the ESC/ESH guidelines recommend a first-line treatment approach using a combination of a RAAS inhibitor (either an ACE inhibitor or an ARB) with a calcium channel blocker (CCB) or a diuretic [29]. This evidence concerns the gene ACE and diabetes mellitus.